Trial Profile
Prospective study of Riociguat on Hemodynamic Responses to Exercise in Chronic thromboembolic pulmonary hypertension Patients After Balloon Pulmonary Angioplasty
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Dec 2018
Price :
$35
*
At a glance
- Drugs Riociguat (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- 15 Dec 2018 New trial record
- 14 Nov 2018 Results presented at the 91st Annual Scientific Sessions of the American Heart Association